Technology for direct cell reprogramming
Interviewee/Contributor
Julian Gough
Organisation
Mogrify Ltd
Research Directory
Exploring new business models for antibiotics
Interviewee/ContributorHeather GrazOrganisationNeem Biotech LtdVivoryon Therapeutics tests Alzheimer's drug
Interviewee/ContributorUlrich DauerOrganisationVivoryon Therapeutics AGGut microbiota is new frontier in CNS research
Interviewee/ContributorPeter CharlishOrganisationMedNousTaking on the Alzheimer's conundrum
Interviewee/ContributorReisa SperlingOrganisationHarvard Medical SchoolRevisiting antibody-drug conjugates
Interviewee/ContributorChris MartinOrganisationADC Therapeutics SAWhy private equity is investing in biopharma
Interviewee/ContributorEmma DabbsOrganisationNovasecta LtdFinding a treatment for mesothelioma
Interviewee/ContributorRob MeijerOrganisationAmphera BVDual inhibition of intracellular enzymes
Interviewee/ContributorTara Rheault Margot MacDonald-BerkoOrganisationVerona Pharma PlcInvestors show caution about biotechs
Interviewee/ContributorWilliam EllingtonOrganisationMedNous